First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence

Leptomeningeal metastasis (LM) from lung cancer has poor prognosis, and effective therapy has not been established. We present the case of a 54-year-old man with LM from lung adenocarcinoma harboring EGFR L858R point mutation, who received osimertinib as first-line therapy. He had previously undergo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int Cancer Conf J
Главные авторы: Ono, Yuki, Takada, Kazuki, Osoegawa, Atsushi, Kinoshita, Fumihiko, Oba, Taro, Tsukamoto, Shuichi, Tagawa, Tetsuzo, Oda, Yoshinao, Mori, Masaki
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Singapore 2020
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797384/
https://ncbi.nlm.nih.gov/pubmed/33489707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00453-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы